Oncology Biosimilars Market Report

Global Oncology Biosimilars Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Feb 19, 2021
  • PAGES：218
  • REPORT CODE：GMM616496
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Oncology Biosimilars is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.8% during the forecast period. The research provides insights for the global Oncology Biosimilars market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Oncology Biosimilars industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Oncology Biosimilars Market Segmentations:

    By Players:

    • Teva Pharmaceutical Industries Ltd

    • BIOCAD

    • STADA Arzneimittel AG

    • Sandoz International

    • Pfizer

    • Celltrion

    • Dr Reddy’s Laboratories

    • Biocon

    • Apotex

    • Intas Pharmaceuticals

    By Types:

    • mAb

    • Immunomodulators

    • Hematopoietic Agents

    • G-CSF

    • Others

    By End-User:

    • Retail Pharmacies

    • Hospital Pharmacy

    • Online Pharmacy

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Oncology Biosimilars Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Oncology Biosimilars Market Size and Growth Rate of mAb from 2014 to 2026

      • 1.3.2 Global Oncology Biosimilars Market Size and Growth Rate of Immunomodulators from 2014 to 2026

      • 1.3.3 Global Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026

      • 1.3.4 Global Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026

      • 1.3.5 Global Oncology Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

      • 1.4.2 Global Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

      • 1.4.3 Global Oncology Biosimilars Market Size and Growth Rate of Online Pharmacy from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Oncology Biosimilars Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Oncology Biosimilars Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Oncology Biosimilars by Major Types

      • 3.4.1 Oncology Biosimilars Market Size and Growth Rate of mAb

      • 3.4.2 Oncology Biosimilars Market Size and Growth Rate of Immunomodulators

      • 3.4.3 Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents

      • 3.4.4 Oncology Biosimilars Market Size and Growth Rate of G-CSF

      • 3.4.5 Oncology Biosimilars Market Size and Growth Rate of Others

    4 Segmentation of Oncology Biosimilars Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Oncology Biosimilars by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Oncology Biosimilars in Retail Pharmacies

      • 4.4.2 Market Size and Growth Rate of Oncology Biosimilars in Hospital Pharmacy

      • 4.4.3 Market Size and Growth Rate of Oncology Biosimilars in Online Pharmacy

    5 Market Analysis by Major Regions

    • 5.1 Global Oncology Biosimilars Production Analysis by Major Regions

    • 5.2 Global Oncology Biosimilars Consumption Analysis by Major Regions

    • 5.3 Global Oncology Biosimilars Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Oncology Biosimilars Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Oncology Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Oncology Biosimilars Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Oncology Biosimilars Production, Import, Consumption and Export Analysis

    6 Product Commodity of Oncology Biosimilars Market in Major Countries

    • 6.1 Top 5 Export Countries in Oncology Biosimilars market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Oncology Biosimilars market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Oncology Biosimilars market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Oncology Biosimilars market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Oncology Biosimilars market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Oncology Biosimilars market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Oncology Biosimilars Landscape Analysis

    • 7.1 North America Oncology Biosimilars Landscape Analysis by Major Types

    • 7.2 North America Oncology Biosimilars Landscape Analysis by Major End-Users

    • 7.3 North America Oncology Biosimilars Landscape Analysis by Major Countries

      • 7.3.1 United States Oncology Biosimilars Market Volume and Growth Rate

      • 7.3.2 Canada Oncology Biosimilars Market Volume and Growth Rate

      • 7.3.3 Mexico Oncology Biosimilars Market Volume and Growth Rate

    8 Europe Oncology Biosimilars Landscape Analysis

    • 8.1 Europe Oncology Biosimilars Landscape Analysis by Major Types

    • 8.2 Europe Oncology Biosimilars Landscape Analysis by Major End-Users

    • 8.3 Europe Oncology Biosimilars Landscape Analysis by Major Countries

      • 8.3.1 Germany Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.2 UK Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.3 France Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.4 Italy Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.6 Spain Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.7 Belgium Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.8 Poland Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.9 Russia Oncology Biosimilars Market Volume and Growth Rate

      • 8.3.10 Turkey Oncology Biosimilars Market Volume and Growth Rate

    9 Asia Pacific Oncology Biosimilars Landscape Analysis

    • 9.1 Asia Pacific Oncology Biosimilars Landscape Analysis by Major Types

    • 9.2 Asia Pacific Oncology Biosimilars Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Oncology Biosimilars Landscape Analysis by Major Countries

      • 9.3.1 China Oncology Biosimilars Market Volume and Growth Rate

      • 9.3.2 Japan Oncology Biosimilars Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Oncology Biosimilars Market Volume and Growth Rate

      • 9.3.4 India Oncology Biosimilars Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Oncology Biosimilars Market Volume and Growth Rate

      • 9.3.6 South Korea Oncology Biosimilars Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Oncology Biosimilars Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Oncology Biosimilars Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Oncology Biosimilars Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Oncology Biosimilars Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Oncology Biosimilars Market Volume and Growth Rate

      • 10.3.2 Brazil Oncology Biosimilars Market Volume and Growth Rate

      • 10.3.3 Nigeria Oncology Biosimilars Market Volume and Growth Rate

      • 10.3.4 South Africa Oncology Biosimilars Market Volume and Growth Rate 

      • 10.3.5 Argentina Oncology Biosimilars Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Teva Pharmaceutical Industries Ltd

      • 11.1.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 BIOCAD

      • 11.2.1 BIOCAD Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 STADA Arzneimittel AG

      • 11.3.1 STADA Arzneimittel AG Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Sandoz International

      • 11.4.1 Sandoz International Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Pfizer

      • 11.5.1 Pfizer Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Celltrion

      • 11.6.1 Celltrion Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Dr Reddy’s Laboratories

      • 11.7.1 Dr Reddy’s Laboratories Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Biocon

      • 11.8.1 Biocon Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Apotex

      • 11.9.1 Apotex Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Intas Pharmaceuticals

      • 11.10.1 Intas Pharmaceuticals Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 116 Figures and 201 Tables)

    • Figure Product Picture

    • Figure Oncology Biosimilars Market Size and Growth Rate of mAb from 2014 to 2026

    • Figure Oncology Biosimilars Market Size and Growth Rate of Immunomodulators from 2014 to 2026

    • Figure Oncology Biosimilars Market Size and Growth Rate of Hematopoietic Agents from 2014 to 2026

    • Figure Oncology Biosimilars Market Size and Growth Rate of G-CSF from 2014 to 2026

    • Figure Oncology Biosimilars Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Oncology Biosimilars Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Global Oncology Biosimilars Market Size and Growth Rate of Hospital Pharmacy from 2014 to 2026

    • Figure Global Oncology Biosimilars Market Size and Growth Rate of Online Pharmacy from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Oncology Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Oncology Biosimilars Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Oncology Biosimilars

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Oncology Biosimilars by Different Types from 2014 to 2026

    • Table Consumption Share of Oncology Biosimilars by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of mAb

    • Figure Market Size and Growth Rate of Immunomodulators

    • Figure Market Size and Growth Rate of Hematopoietic Agents

    • Figure Market Size and Growth Rate of G-CSF

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Oncology Biosimilars by Different End-Users from 2014 to 2026

    • Table Consumption Share of Oncology Biosimilars by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Hospital Pharmacy

    • Figure Market Size and Growth Rate of Online Pharmacy

    • Table Global Oncology Biosimilars Production by Major Regions

    • Table Global Oncology Biosimilars Production Share by Major Regions

    • Figure Global Oncology Biosimilars Production Share by Major Regions in 2014

    • Figure Global Oncology Biosimilars Production Share by Major Regions in 2018

    • Figure Global Oncology Biosimilars Production Share by Major Regions in 2026

    • Table Global Oncology Biosimilars Consumption by Major Regions

    • Table Global Oncology Biosimilars Consumption Share by Major Regions

    • Figure Global Oncology Biosimilars Consumption Share by Major Regions in 2014

    • Figure Global Oncology Biosimilars Consumption Share by Major Regions in 2018

    • Figure Global Oncology Biosimilars Consumption Share by Major Regions in 2026

    • Table North America Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Europe Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Oncology Biosimilars Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Oncology Biosimilars market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Oncology Biosimilars market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Oncology Biosimilars market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Oncology Biosimilars market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table North America Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure North America Oncology Biosimilars Consumption Share by Types in 2014

    • Figure North America Oncology Biosimilars Consumption Share by Types in 2018

    • Figure North America Oncology Biosimilars Consumption Share by Types in 2026

    • Table North America Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table North America Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure North America Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure North America Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure North America Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table North America Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table North America Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2014

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2018

    • Figure North America Oncology Biosimilars Consumption Share by Major Countries in 2026

    • Figure United States Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Europe Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Europe Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Europe Oncology Biosimilars Consumption Share by Types in 2026

    • Table Europe Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Europe Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Europe Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Europe Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Europe Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Oncology Biosimilars Consumption Share by Major Countries in 2014

    • Figure Europe Oncology Biosimilars Consumption Share by Major Countries in 2018

    • Figure Europe Oncology Biosimilars Consumption Share by Major Countries in 2026

    • Figure Germany Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure France Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Asia Pacific Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by Types in 2026

    • Table Asia Pacific Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Asia Pacific Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Oncology Biosimilars Consumption Share by Major Countries in 2026

    • Figure China Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandOncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure India Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Oncology Biosimilars Consumption Share by Major Countries in 2026

    • Figure GCC Countries Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Oncology Biosimilars Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of BIOCAD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BIOCAD

    • Figure Sales and Growth Rate Analysis of BIOCAD

    • Figure Revenue and Market Share Analysis of BIOCAD

    • Table Product and Service Introduction of BIOCAD

    • Table Company Profile and Development Status of STADA Arzneimittel AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of STADA Arzneimittel AG

    • Figure Sales and Growth Rate Analysis of STADA Arzneimittel AG

    • Figure Revenue and Market Share Analysis of STADA Arzneimittel AG

    • Table Product and Service Introduction of STADA Arzneimittel AG

    • Table Company Profile and Development Status of Sandoz International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International

    • Figure Sales and Growth Rate Analysis of Sandoz International

    • Figure Revenue and Market Share Analysis of Sandoz International

    • Table Product and Service Introduction of Sandoz International

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion

    • Table Company Profile and Development Status of Dr Reddy’s Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dr Reddy’s Laboratories

    • Figure Sales and Growth Rate Analysis of Dr Reddy’s Laboratories

    • Figure Revenue and Market Share Analysis of Dr Reddy’s Laboratories

    • Table Product and Service Introduction of Dr Reddy’s Laboratories

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of Apotex

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Apotex

    • Figure Sales and Growth Rate Analysis of Apotex

    • Figure Revenue and Market Share Analysis of Apotex

    • Table Product and Service Introduction of Apotex

    • Table Company Profile and Development Status of Intas Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Intas Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Intas Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Intas Pharmaceuticals

    • Table Product and Service Introduction of Intas Pharmaceuticals


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US